Clinical Trial Update: Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 study investigating the impact of obeticholic acid on lipoprotein metabolism in patients with primary biliary cirrhosis has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cirrhosis

Drugs mentioned

• Obeticholic acid (obeticholic acid)

Snippet

Sponsor: Intercept Pharmaceuticals | Conditions: Primary Biliary Cirrhosis | Phase 2 | Status: COMPLETED | Results posted: 2016-10-19